How should tetrofosmin (radiopharmaceutical) be administered for myocardial perfusion SPECT imaging in an adult, including dosing, timing, contraindications, and alternatives?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tetrofosmin Administration for Myocardial Perfusion SPECT Imaging

For adult myocardial perfusion SPECT imaging, administer Tc-99m tetrofosmin intravenously at doses of 10-30 mCi (370-1110 MBq) depending on the protocol, with stress imaging beginning 15-20 minutes post-injection and rest imaging at 30 minutes post-injection. 1

Dosing Protocols

Standard Adult Dosing

The FDA-approved dosing range is 10-30 mCi (370-1110 MBq) administered intravenously 1. The specific dose depends on your imaging protocol:

One-Day Rest/Stress Protocol:

  • Rest injection: 6-10 mCi (259-370 MBq)
  • Stress injection: 20-30 mCi (777-1110 MBq), administered 3-4 hours after rest
  • This protocol delivers an effective radiation dose of 9.8-16.3 mSv 2

Two-Day Protocol:

  • Each injection: 20-25 mCi
  • Allows for lower total radiation exposure per imaging session

Dose Optimization Strategies

Consider stress-first/stress-only imaging to minimize radiation exposure 3. If stress images are normal, rest imaging can be omitted, reducing total radiation dose by approximately 50%. This approach is particularly valuable for patients with low-to-intermediate pretest probability of coronary artery disease.

Advanced camera systems (CZT detectors, high-efficiency cameras) allow further dose reduction to as low as 6 mCi rest/20 mCi stress while maintaining diagnostic image quality 4, 5.

Timing of Image Acquisition

Stress imaging: Begin 15-20 minutes post-injection 6, 7, 8

  • Tetrofosmin's rapid hepatobiliary clearance allows earlier imaging compared to sestamibi
  • Heart-to-background ratios are optimal at these early timepoints
  • Earlier imaging (15 minutes) reduces patient throughput time by approximately 15 minutes compared to sestamibi 8

Rest imaging: Begin 30 minutes post-injection 6, 7

  • Allows adequate clearance of hepatobiliary activity
  • Heart-to-liver and heart-to-gastrointestinal ratios exceed 1.0 by 30 minutes 7

Acquisition duration: 10-20 minutes for standard SPECT systems; 5-7 minutes for high-efficiency systems 9, 4

Preparation and Administration

Radiopharmaceutical Preparation

  1. Add up to 360 mCi Tc-99m pertechnetate in 6-12 mL saline to the tetrofosmin kit vial (maximum concentration: 30 mCi/mL)
  2. Insert filtered vent needle and withdraw 3 mL gas
  3. Mix gently and let stand 15 minutes at room temperature
  4. Verify radiochemical purity ≥90% before administration
  5. Store at 2-8°C and use within 12 hours 1

Patient Preparation

  • Fasting: 4-6 hours before stress imaging (reduces hepatobiliary activity)
  • Caffeine restriction: 12-24 hours before pharmacological stress
  • Beta-blockers: Hold if exercise stress planned (unless contraindicated)
  • Nitrates: Hold before stress imaging per institutional protocol

Contraindications and Precautions

Absolute Contraindications to Stress Testing

  • Acute myocardial infarction within 48 hours
  • Unstable angina not stabilized by medical therapy
  • Uncontrolled cardiac arrhythmias causing symptoms or hemodynamic compromise
  • Symptomatic severe aortic stenosis
  • Acute pulmonary embolism or pulmonary infarction
  • Acute myocarditis or pericarditis

Relative Contraindications

  • Known severe left main coronary stenosis
  • Moderate stenotic valvular heart disease
  • Severe hypertension (systolic >200 mmHg or diastolic >110 mmHg)
  • Tachyarrhythmias or bradyarrhythmias
  • High-degree atrioventricular block

Pregnancy and Lactation

Tetrofosmin delivers radiation exposure to the fetus. Use only when benefits clearly outweigh risks. If administered during lactation, interrupt breastfeeding for 24-48 hours.

Safety Profile

Tetrofosmin is exceptionally safe with complication rates from stress testing at 0.01% mortality and 0.02% morbidity 10. The radiation exposure (10 mSv for a 1,000 MBq study) is comparable to CT angiography and coronary angiography 10. This translates to a 1 in 1,800 lifetime cancer risk, which is minimal compared to the 1 in 3 baseline cancer risk in the general population.

Alternatives to Tetrofosmin

Tc-99m Sestamibi

  • Similar diagnostic accuracy to tetrofosmin 2
  • Disadvantage: Requires longer injection-to-imaging times (60 minutes rest, 30-45 minutes stress)
  • Higher repeat scan rates: 21.4% vs 10% for rest, 16.4% vs 7.9% for stress 6
  • Slower hepatobiliary clearance increases study duration by 30-45 minutes 8

PET Tracers (Superior Alternative When Available)

Rb-82 chloride:

  • Effective dose: 2-4 mSv (significantly lower than SPECT) 2
  • Requires pharmacological stress only (short half-life)
  • Superior image quality and quantification of myocardial blood flow

N-13 ammonia:

  • Effective dose: 2.2 mSv for rest-stress study 2
  • Excellent for quantifying myocardial blood flow
  • Requires on-site cyclotron (limited availability)

Thallium-201

Avoid thallium-201 due to significantly higher radiation exposure (18 mSv for 80 MBq) 10 and inferior imaging characteristics 3, 2. The only remaining indication is viability assessment when redistribution imaging is specifically needed.

Common Pitfalls

  1. Hepatobiliary interference: Imaging too early at rest (<30 minutes) increases repeat scan rates due to liver/gallbladder activity
  2. Inadequate stress: Submaximal heart rate response reduces sensitivity for detecting ischemia
  3. Patient motion: Causes artifacts; ensure patient comfort and minimize acquisition time
  4. Attenuation artifacts: Use attenuation correction when available to reduce false-positive rates
  5. Inadequate dose for body habitus: Larger patients may require doses at the higher end of the range for adequate count statistics

References

Research

Diagnostic performance of low-dose rest/stress Tc-99m tetrofosmin myocardial perfusion SPECT using the 530c CZT camera: quantitative vs visual analysis.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2014

Research

Semiconductor detectors allow low-dose-low-dose 1-day SPECT myocardial perfusion imaging.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011

Research

Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993

Research

Efficiency of tetrofosmin versus sestamibi achieved through shorter injection-to-imaging times: A systematic review of the literature.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021

Guideline

myocardial perfusion scintigraphy: the evidence.

European Journal of Nuclear Medicine and Molecular Imaging, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.